{"id":393673,"date":"2025-02-11T00:01:00","date_gmt":"2025-02-10T23:01:00","guid":{"rendered":"https:\/\/medizinonline.com\/sglt-2-i-considerare-per-tutti-i-pazienti-con-ckd\/"},"modified":"2025-02-10T21:46:38","modified_gmt":"2025-02-10T20:46:38","slug":"sglt-2-i-considerare-per-tutti-i-pazienti-con-ckd","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/sglt-2-i-considerare-per-tutti-i-pazienti-con-ckd\/","title":{"rendered":"SGLT-2-i: considerare per tutti i pazienti con CKD"},"content":{"rendered":"\n<p><strong>Misure mirate di diagnosi precoce e trattamento tempestivo della<em> malattia renale<\/em> cronica (CKD) sono estremamente importanti per arrestare la progressione e gestire le complicanze. La determinazione dell&#8217;albuminuria permette di fare una diagnosi pi\u00f9 precoce rispetto all&#8217;esame del solo eGFR. Gli inibitori SGLT-2, originariamente sviluppati per il trattamento del diabete, non solo sono cardioprotettivi, ma contrastano anche la progressione della perdita di funzionalit\u00e0 renale.    <\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fsglt-2-i-considerare-per-tutti-i-pazienti-con-ckd%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Misure mirate di diagnosi precoce e trattamento tempestivo della malattia renale cronica (CKD) sono estremamente importanti per arrestare la progressione e gestire le complicanze. La determinazione dell&#8217;albuminuria permette di fare&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fsglt-2-i-considerare-per-tutti-i-pazienti-con-ckd%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":393675,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Malattia renale cronica  ","footnotes":""},"category":[11550,11366,11306,11420,11522],"tags":[12963,12955,17711,12969,18622],"powerkit_post_featured":[],"class_list":["post-393673","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-it","category-cardiologia-it","category-medicina-interna-generale","category-nefrologia-it","category-rapporti-del-congresso","tag-albuminuria-it","tag-ckd-it","tag-egfr-it","tag-malattia-renale-cronica","tag-sglt-2-i-it","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-26 09:18:50","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":393668,"slug":"sglt-2-i-considere-para-todos-os-doentes-com-drc","post_title":"SGLT-2-i: considere para todos os doentes com DRC","href":"https:\/\/medizinonline.com\/pt-pt\/sglt-2-i-considere-para-todos-os-doentes-com-drc\/"},"es_ES":{"locale":"es_ES","id":393587,"slug":"sglt-2-i-considerar-para-todos-los-pacientes-con-erc","post_title":"SGLT-2-i: considerar para todos los pacientes con ERC","href":"https:\/\/medizinonline.com\/es\/sglt-2-i-considerar-para-todos-los-pacientes-con-erc\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/393673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=393673"}],"version-history":[{"count":3,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/393673\/revisions"}],"predecessor-version":[{"id":394631,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/393673\/revisions\/394631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/393675"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=393673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=393673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=393673"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=393673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}